Renvela Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4
Conditions:   CKD Stage 3b;   CKD Stage 4 Intervention:   Drug: Sevelamer Carbonate Sponsor:   Fan Fan Hou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2018 Category: Research Source Type: clinical trials

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
Condition:   Hyperphosphatemia Interventions:   Drug: Placebo;   Drug: Sevelamer Carbonate (GZ419831) Sponsor:   Sanofi Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2016 Category: Research Source Type: clinical trials